Neogen Chemicals Limited (NEOGEN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.308x

Based on the latest financial reports, Neogen Chemicals Limited (NEOGEN) has a cash flow conversion efficiency ratio of -0.308x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-2.46 Billion ≈ $-26.62 Million USD) by net assets (Rs8.00 Billion ≈ $86.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NEOGEN market cap overview for the company's overall valuation and market capitalisation.

Neogen Chemicals Limited - Cash Flow Conversion Efficiency Trend (2014–2026)

This chart illustrates how Neogen Chemicals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Neogen Chemicals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neogen Chemicals Limited ranked by their cash flow conversion efficiency. Explore NEOGEN cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
GH RESEARCH PLC DL-025
F:1KA
N/A
Third Coast Bancshares, Inc.
NYSE:TCBX
0.009x
Shandong Weida Machinery Co Ltd
SHE:002026
0.025x
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
N/A
Cydsa S.A.B. de C.V
MX:CYDSASAA
0.068x
Shinyoung Securities Co. Ltd.
KO:001720
-0.156x
Zhejiang Fuchunjiang Environmental Thermoelectric Co Ltd
SHE:002479
0.031x
Magic Software Enterprises Ltd
TA:MGIC
0.064x

Annual Cash Flow Conversion Efficiency for Neogen Chemicals Limited (2014–2026)

The table below shows the annual cash flow conversion efficiency of Neogen Chemicals Limited from 2014 to 2026. View Neogen Chemicals Limited (NEOGEN) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs8.16 Billion
≈ $88.27 Million
Rs-3.37 Billion
≈ $-36.47 Million
-0.413x -266.41%
2025-03-31 Rs7.89 Billion
≈ $85.37 Million
Rs1.96 Billion
≈ $21.19 Million
0.248x +747.53%
2024-03-31 Rs7.60 Billion
≈ $82.22 Million
Rs-291.50 Million
≈ $-3.15 Million
-0.038x +39.04%
2023-03-31 Rs4.83 Billion
≈ $52.18 Million
Rs-303.50 Million
≈ $-3.28 Million
-0.063x -2059.41%
2022-03-31 Rs4.39 Billion
≈ $47.50 Million
Rs14.10 Million
≈ $152.49K
0.003x -99.30%
2021-03-31 Rs1.83 Billion
≈ $19.79 Million
Rs835.70 Million
≈ $9.04 Million
0.457x +306.51%
2020-03-31 Rs1.56 Billion
≈ $16.90 Million
Rs-345.47 Million
≈ $-3.74 Million
-0.221x -322.15%
2019-03-31 Rs702.01 Million
≈ $7.59 Million
Rs-36.77 Million
≈ $-397.64K
-0.052x -122.13%
2018-03-31 Rs500.62 Million
≈ $5.41 Million
Rs118.49 Million
≈ $1.28 Million
0.237x +4751.83%
2017-03-31 Rs422.28 Million
≈ $4.57 Million
Rs2.06 Million
≈ $22.28K
0.005x -98.44%
2016-03-31 Rs275.49 Million
≈ $2.98 Million
Rs85.90 Million
≈ $928.98K
0.312x -15.37%
2015-03-31 Rs234.87 Million
≈ $2.54 Million
Rs86.53 Million
≈ $935.79K
0.368x +146.03%
2014-03-31 Rs195.93 Million
≈ $2.12 Million
Rs29.34 Million
≈ $317.30K
0.150x --

About Neogen Chemicals Limited

NSE:NEOGEN India Specialty Chemicals
Market Cap
$736.87 Million
Rs68.14 Billion INR
Market Cap Rank
#10383 Global
#516 in India
Share Price
Rs2488.40
Change (1 day)
+3.87%
52-Week Range
Rs979.80 - Rs2488.40
All Time High
Rs2488.40
About

Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds … Read more